Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Protocol to assess the suppression of T-cell proliferation by human MDSC.

Bruger AM, Vanhaver C, Bruderek K, Amodio G, Tavukçuoğlu E, Esendagli G, Gregori S, Brandau S, van der Bruggen P.

Methods Enzymol. 2020;632:155-192. doi: 10.1016/bs.mie.2019.05.046. Epub 2019 Jul 8.

PMID:
32000895
2.

Surgical vacuum filter-derived stromal cells are superior in proliferation to human bone marrow aspirate.

Henze K, Herten M, Haversath M, Busch A, Brandau S, Hackel A, Flohé SB, Jäger M.

Stem Cell Res Ther. 2019 Nov 21;10(1):338. doi: 10.1186/s13287-019-1461-0.

3.

Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue.

Si Y, Merz SF, Jansen P, Wang B, Bruderek K, Altenhoff P, Mattheis S, Lang S, Gunzer M, Klode J, Squire A, Brandau S.

Sci Immunol. 2019 Oct 18;4(40). pii: eaaw9159. doi: 10.1126/sciimmunol.aaw9159.

PMID:
31628161
4.

EGFR-Specific Tyrosine Kinase Inhibitor Modifies NK Cell-Mediated Antitumoral Activity against Ovarian Cancer Cells.

Mallmann-Gottschalk N, Sax Y, Kimmig R, Lang S, Brandau S.

Int J Mol Sci. 2019 Sep 22;20(19). pii: E4693. doi: 10.3390/ijms20194693.

5.

Distinct Spatio-Temporal Dynamics of Tumor-Associated Neutrophils in Small Tumor Lesions.

Sody S, Uddin M, Grüneboom A, Görgens A, Giebel B, Gunzer M, Brandau S.

Front Immunol. 2019 Jun 25;10:1419. doi: 10.3389/fimmu.2019.01419. eCollection 2019.

6.

High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity.

Willebrand R, Hamad I, Van Zeebroeck L, Kiss M, Bruderek K, Geuzens A, Swinnen D, Côrte-Real BF, Markó L, Lebegge E, Laoui D, Kemna J, Kammertoens T, Brandau S, Van Ginderachter JA, Kleinewietfeld M.

Front Immunol. 2019 Jun 4;10:1141. doi: 10.3389/fimmu.2019.01141. eCollection 2019.

7.

Chemoirradiated neutrophils and T cells differentially affect immune functions of APCs.

Franklin C, Bruderek K, Schilling B, Brandau S.

J Leukoc Biol. 2019 Aug;106(2):481-493. doi: 10.1002/JLB.5A0618-242R. Epub 2019 May 10.

PMID:
31075186
8.

MDSC and beyond: a symposium-in-writing on myeloid cells with immunoregulatory activity by members of the Mye-EUNITER network.

Brandau S.

Cancer Immunol Immunother. 2019 Apr;68(4):531-532. doi: 10.1007/s00262-019-02325-9. No abstract available.

PMID:
30887118
9.

Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.

Cassetta L, Baekkevold ES, Brandau S, Bujko A, Cassatella MA, Dorhoi A, Krieg C, Lin A, Loré K, Marini O, Pollard JW, Roussel M, Scapini P, Umansky V, Adema GJ.

Cancer Immunol Immunother. 2019 Apr;68(4):687-697. doi: 10.1007/s00262-019-02302-2. Epub 2019 Jan 25. Review.

10.

T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response.

Kansy BA, Shayan G, Jie HB, Gibson SP, Lei YL, Brandau S, Lang S, Schmitt NC, Ding F, Lin Y, Ferris RL.

Oncoimmunology. 2018 Aug 24;7(11):e1494112. doi: 10.1080/2162402X.2018.1494112. eCollection 2018.

11.

NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils.

Pylaeva E, Harati MD, Spyra I, Bordbari S, Strachan S, Thakur BK, Höing B, Franklin C, Skokowa J, Welte K, Schadendorf D, Bankfalvi A, Brandau S, Lang S, Jablonska J.

Int J Cancer. 2019 Jan 1;144(1):136-149. doi: 10.1002/ijc.31808. Epub 2018 Oct 30.

12.

Interactions among myeloid regulatory cells in cancer.

Umansky V, Adema GJ, Baran J, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coaña Y, Santegoets KCM, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG.

Cancer Immunol Immunother. 2019 Apr;68(4):645-660. doi: 10.1007/s00262-018-2200-6. Epub 2018 Jul 12. Review.

PMID:
30003321
13.

Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.

Lang S, Bruderek K, Kaspar C, Höing B, Kanaan O, Dominas N, Hussain T, Droege F, Eyth C, Hadaschik B, Brandau S.

Clin Cancer Res. 2018 Oct 1;24(19):4834-4844. doi: 10.1158/1078-0432.CCR-17-3726. Epub 2018 Jun 18.

14.

How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.

Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S.

Cancer Immunol Immunother. 2019 Apr;68(4):631-644. doi: 10.1007/s00262-018-2170-8. Epub 2018 May 21. Review.

PMID:
29785656
15.

CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.

Schlüter A, Weller P, Kanaan O, Nel I, Heusgen L, Höing B, Haßkamp P, Zander S, Mandapathil M, Dominas N, Arnolds J, Stuck BA, Lang S, Bankfalvi A, Brandau S.

BMC Cancer. 2018 Mar 9;18(1):272. doi: 10.1186/s12885-018-4180-5.

16.

Stromal versus tumoral inflammation differentially contribute to metastasis and poor survival in laryngeal squamous cell carcinoma.

Höing B, Kanaan O, Altenhoff P, Petri R, Thangavelu K, Schlüter A, Lang S, Bankfalvi A, Brandau S.

Oncotarget. 2018 Jan 3;9(9):8415-8426. doi: 10.18632/oncotarget.23865. eCollection 2018 Feb 2.

17.

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.

Kansy BA, Concha-Benavente F, Srivastava RM, Jie HB, Shayan G, Lei Y, Moskovitz J, Moy J, Li J, Brandau S, Lang S, Schmitt NC, Freeman GJ, Gooding WE, Clump DA, Ferris RL.

Cancer Res. 2017 Nov 15;77(22):6353-6364. doi: 10.1158/0008-5472.CAN-16-3167. Epub 2017 Sep 13.

18.

Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function.

Petri RM, Hackel A, Hahnel K, Dumitru CA, Bruderek K, Flohe SB, Paschen A, Lang S, Brandau S.

Stem Cell Reports. 2017 Sep 12;9(3):985-998. doi: 10.1016/j.stemcr.2017.06.020. Epub 2017 Aug 3.

19.

Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth.

Klein JC, Moses K, Zelinskyy G, Sody S, Buer J, Lang S, Helfrich I, Dittmer U, Kirschning CJ, Brandau S.

Nat Commun. 2017 Mar 16;8:14600. doi: 10.1038/ncomms14600.

20.

Lost in neutrophil heterogeneity? CD10!

Brandau S, Hartl D.

Blood. 2017 Mar 9;129(10):1240-1241. doi: 10.1182/blood-2017-01-761585. No abstract available.

PMID:
28280045
21.

Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression.

Kalkavan H, Sharma P, Kasper S, Helfrich I, Pandyra AA, Gassa A, Virchow I, Flatz L, Brandenburg T, Namineni S, Heikenwalder M, Höchst B, Knolle PA, Wollmann G, von Laer D, Drexler I, Rathbun J, Cannon PM, Scheu S, Bauer J, Chauhan J, Häussinger D, Willimsky G, Löhning M, Schadendorf D, Brandau S, Schuler M, Lang PA, Lang KS.

Nat Commun. 2017 Mar 1;8:14447. doi: 10.1038/ncomms14447.

22.

Community Audit of Social, Civil, and Activity Domains in Diverse Environments (CASCADDE).

Knapp EA, Nau C, Brandau S, DeWalle J, Hirsch AG, Bailey-Davis L, Schwartz BS, Glass TA.

Am J Prev Med. 2017 Apr;52(4):530-540. doi: 10.1016/j.amepre.2016.11.013. Epub 2017 Feb 13.

23.

Adenosine Producing Mesenchymal Stem Cells.

Schuler PJ, Brandau S.

Stem Cells. 2017 Jun;35(6):1647-1648. doi: 10.1002/stem.2532. Epub 2016 Nov 22.

24.

Vaccination Against Human Papilloma Viruses Leads to a Favorable Cytokine Profile of Specific T Cells.

Luckau S, Wehrs TP, Brandau S, Horn PA, Lindemann M.

J Immunother. 2016 Oct;39(8):316-20. doi: 10.1097/CJI.0000000000000137.

PMID:
27548034
25.

Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients.

Cui R, Rekasi H, Hepner-Schefczyk M, Fessmann K, Petri RM, Bruderek K, Brandau S, Jäger M, Flohé SB.

Stem Cell Res Ther. 2016 Jul 7;7(1):88. doi: 10.1186/s13287-016-0353-9.

26.

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards.

Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, Rodriguez PC, Sica A, Umansky V, Vonderheide RH, Gabrilovich DI.

Nat Commun. 2016 Jul 6;7:12150. doi: 10.1038/ncomms12150. Review.

27.

CD11c.DTR mice develop a fatal fulminant myocarditis after local or systemic treatment with diphtheria toxin.

Männ L, Kochupurakkal N, Martin C, Verjans E, Klingberg A, Sody S, Kraus A, Dalimot J, Bergmüller E, Jung S, Voortman S, Winterhager E, Brandau S, Garbi N, Kurrer M, Eriksson U, Gunzer M, Hasenberg M.

Eur J Immunol. 2016 Aug;46(8):2028-42. doi: 10.1002/eji.201546245. Epub 2016 Jun 8.

28.

Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells.

Moses K, Brandau S.

Semin Immunol. 2016 Apr;28(2):187-96. doi: 10.1016/j.smim.2016.03.018. Epub 2016 Apr 7. Review.

PMID:
27067179
29.

Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.

Klein JC, Wild CA, Lang S, Brandau S.

Cancer Immunol Immunother. 2016 Jun;65(6):689-700. doi: 10.1007/s00262-016-1828-3. Epub 2016 Mar 31.

PMID:
27034235
30.

Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.

Schuler PJ, Westerkamp AM, Kansy BA, Bruderek K, Dissmann PA, Dumitru CA, Lang S, Jackson EK, Brandau S.

Immunobiology. 2017 Jan;222(1):66-74. doi: 10.1016/j.imbio.2016.01.013. Epub 2016 Jan 30.

PMID:
26898925
31.

Survival of residual neutrophils and accelerated myelopoiesis limit the efficacy of antibody-mediated depletion of Ly-6G+ cells in tumor-bearing mice.

Moses K, Klein JC, Männ L, Klingberg A, Gunzer M, Brandau S.

J Leukoc Biol. 2016 Jun;99(6):811-23. doi: 10.1189/jlb.1HI0715-289R. Epub 2016 Jan 27.

PMID:
26819319
32.

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.

Mandruzzato S, Brandau S, Britten CM, Bronte V, Damuzzo V, Gouttefangeas C, Maurer D, Ottensmeier C, van der Burg SH, Welters MJ, Walter S.

Cancer Immunol Immunother. 2016 Feb;65(2):161-9. doi: 10.1007/s00262-015-1782-5. Epub 2016 Jan 4.

33.

Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human.

Andzinski L, Kasnitz N, Stahnke S, Wu CF, Gereke M, von Köckritz-Blickwede M, Schilling B, Brandau S, Weiss S, Jablonska J.

Int J Cancer. 2016 Apr 15;138(8):1982-93. doi: 10.1002/ijc.29945. Epub 2015 Dec 17.

34.

CD137 Agonist Therapy Can Reprogram Regulatory T Cells into Cytotoxic CD4+ T Cells with Antitumor Activity.

Akhmetzyanova I, Zelinskyy G, Littwitz-Salomon E, Malyshkina A, Dietze KK, Streeck H, Brandau S, Dittmer U.

J Immunol. 2016 Jan 1;196(1):484-92. doi: 10.4049/jimmunol.1403039. Epub 2015 Nov 25.

35.

Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells.

Brandau S, Bruderek K, Hestermann K, Görtz GE, Horstmann M, Mattheis S, Lang S, Eckstein A, Berchner-Pfannschmidt U.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6549-57. doi: 10.1167/iovs.15-16610.

PMID:
26457540
36.

[Immunotherapy in head and neck cancer].

Kansy B, Hussain T, Mattheis S, Wollenberg B, Brandau S, Lang S.

HNO. 2015 Nov;63(11):797-803. doi: 10.1007/s00106-015-0076-8. Review. German.

PMID:
26452491
37.

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease.

Franklin C, Cesko E, Hillen U, Schilling B, Brandau S.

PLoS One. 2015 Aug 4;10(8):e0134518. doi: 10.1371/journal.pone.0134518. eCollection 2015.

38.

Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes.

Hasenberg A, Hasenberg M, Männ L, Neumann F, Borkenstein L, Stecher M, Kraus A, Engel DR, Klingberg A, Seddigh P, Abdullah Z, Klebow S, Engelmann S, Reinhold A, Brandau S, Seeling M, Waisman A, Schraven B, Göthert JR, Nimmerjahn F, Gunzer M.

Nat Methods. 2015 May;12(5):445-52. doi: 10.1038/nmeth.3322. Epub 2015 Mar 16.

PMID:
25775045
39.

Multimodal imaging analysis of an orthotopic head and neck cancer mouse model and application of anti-CD137 tumor immune therapy.

Vahle AK, Hermann S, Schäfers M, Wildner M, Kerem A, Öztürk E, Jure-Kunkel M, Franklin C, Lang S, Brandau S.

Head Neck. 2016 Apr;38(4):542-9. doi: 10.1002/hed.23929. Epub 2015 Jun 16.

PMID:
25482887
40.

Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes.

Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, Mauel K, Jäger M, Flohé SB, Lang S.

PLoS One. 2014 Sep 19;9(9):e106903. doi: 10.1371/journal.pone.0106903. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e114201.

41.

The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer.

Kansy BA, Dißmann PA, Hemeda H, Bruderek K, Westerkamp AM, Jagalski V, Schuler P, Kansy K, Lang S, Dumitru CA, Brandau S.

Stem Cell Res Ther. 2014 Aug 12;5(4):95. doi: 10.1186/scrt484.

42.

Interaction with mesenchymal stem cells provokes natural killer cells for enhanced IL-12/IL-18-induced interferon-gamma secretion.

Thomas H, Jäger M, Mauel K, Brandau S, Lask S, Flohé SB.

Mediators Inflamm. 2014;2014:143463. doi: 10.1155/2014/143463. Epub 2014 Apr 30.

43.

Stimulation of mesenchymal stromal cells (MSCs) via TLR3 reveals a novel mechanism of autocrine priming.

Dumitru CA, Hemeda H, Jakob M, Lang S, Brandau S.

FASEB J. 2014 Sep;28(9):3856-66. doi: 10.1096/fj.14-250159. Epub 2014 May 15.

44.

Bone marrow-derived mesenchymal stem cells migrate to healthy and damaged salivary glands following stem cell infusion.

Schwarz S, Huss R, Schulz-Siegmund M, Vogel B, Brandau S, Lang S, Rotter N.

Int J Oral Sci. 2014 Sep;6(3):154-61. doi: 10.1038/ijos.2014.23. Epub 2014 May 9.

45.

The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer.

Weller P, Bankfalvi A, Gu X, Dominas N, Lehnerdt GF, Zeidler R, Lang S, Brandau S, Dumitru CA.

Eur J Cancer. 2014 May;50(7):1291-300. doi: 10.1016/j.ejca.2014.02.016. Epub 2014 Mar 11.

PMID:
24630394
46.

Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.

Pogorzelski M, Ting S, Gauler TC, Breitenbuecher F, Vossebein I, Hoffarth S, Markowetz J, Lang S, Bergmann C, Brandau S, Jawad JA, Schmid KW, Schuler M, Kasper S.

Cell Death Dis. 2014 Feb 27;5:e1091. doi: 10.1038/cddis.2014.62.

47.

[Trying to unravel an unresolved issue in regenerative medicine: gene expression profiling of MSCs].

Jakob M, Bruderek K, Bootz F, Lang S, Brandau S.

Laryngorhinootologie. 2013 Jul;92(7):462-9. doi: 10.1055/s-0033-1337982. Epub 2013 Apr 16. German.

PMID:
23592442
48.

Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.

Dumitru CA, Lang S, Brandau S.

Semin Cancer Biol. 2013 Jun;23(3):141-8. doi: 10.1016/j.semcancer.2013.02.005. Epub 2013 Feb 26. Review.

PMID:
23485549
49.

The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?

Brandau S, Moses K, Lang S.

Semin Cancer Biol. 2013 Jun;23(3):171-82. doi: 10.1016/j.semcancer.2013.02.007. Epub 2013 Feb 28. Review.

PMID:
23459190
50.

The dichotomy of neutrophil granulocytes in cancer.

Brandau S.

Semin Cancer Biol. 2013 Jun;23(3):139-40. doi: 10.1016/j.semcancer.2013.02.008. Epub 2013 Feb 27.

PMID:
23454237

Supplemental Content

Loading ...
Support Center